Suppr超能文献

阿片类药物管理干预对关键结果的影响:系统评价。

The Effect of Opioid Stewardship Interventions on Key Outcomes: A Systematic Review.

机构信息

From the Abt Associates, Inc., Cambridge, MA.

出版信息

J Patient Saf. 2020 Sep;16(3S Suppl 1):S36-S41. doi: 10.1097/PTS.0000000000000710.

Abstract

OBJECTIVES

We sought to identify potential patient safety practices to reduce high-risk opioid prescribing.

METHODS

We conducted a systematic review of the literature to identify opioid stewardship (OS) strategies implemented in primary care and other settings. Included studies evaluated an OS strategy or a multicomponent OS initiative to address potential harms of opioids and used experimental or quasi-experimental designs.

RESULTS

We identified 14 studies and 1 systematic review that met inclusion criteria. Most studies examined multicomponent OS interventions, which often consisted of guideline-recommended clinical interventions or care processes (e.g., use urine drug screening, check Prescription Drug Monitoring Program), as well as implementation strategies (e.g., dashboards, audit and feedback). Most studies examined the effect of OS interventions on reducing the potential risks of opioids with judicious prescribing and guideline-concordant care (e.g., reduce inappropriate high opioid dosages, avoid co-prescribing opioids and benzodiazepines, use urine drug screening, treatment agreements).

CONCLUSIONS

The strength of the evidence is low to moderate that OS efforts decrease numbers of opioid prescriptions, proportion of patients on long-term opioids, or days' supply. The strength of the evidence for OS initiatives producing significant reductions in opioid dosages was moderate. Future research is needed on the effectiveness of OS interventions, particularly studies with experimental designs and in diverse settings within the health care system.

摘要

目的

我们旨在确定潜在的患者安全实践,以减少高危阿片类药物处方。

方法

我们对文献进行了系统回顾,以确定在初级保健和其他环境中实施的阿片类药物管理 (OS) 策略。纳入的研究评估了 OS 策略或多组分 OS 计划,以解决阿片类药物的潜在危害,并使用实验或准实验设计。

结果

我们确定了 14 项研究和 1 项系统评价符合纳入标准。大多数研究检查了多组分 OS 干预措施,这些干预措施通常包括指南推荐的临床干预措施或护理流程(例如,使用尿液药物筛查、检查处方药物监测计划),以及实施策略(例如,仪表板、审核和反馈)。大多数研究都检查了 OS 干预措施对减少谨慎处方和遵循指南的护理中阿片类药物潜在风险的影响(例如,减少不适当的高阿片类药物剂量、避免同时开阿片类药物和苯二氮䓬类药物、使用尿液药物筛查、治疗协议)。

结论

证据的强度为低到中度,表明 OS 努力可以减少阿片类药物处方的数量、长期使用阿片类药物的患者比例或供应天数。OS 计划在减少阿片类药物剂量方面产生显著效果的证据强度为中度。需要进一步研究 OS 干预措施的有效性,特别是在实验设计和医疗保健系统内的不同环境中进行的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f051/7447172/d5e7eb99f65a/pts-16-s36-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验